Non-coding RNA–mediated mechanisms in malignant transformation
Our research group brings together multidisciplinary expertise to investigate the role of epigenetics and non-coding RNAs in oncological and autoimmune diseases. We focus on the molecular mechanisms driving EBV-associated and non-EBV B-cell lymphomas, as well as solid tumors and autoimmune disorders such as systemic lupus erythematosus. Our projects also explore innovative therapeutic strategies based on nanoparticle-mediated delivery of drugs, microRNAs, and modified microRNAs. The team includes four PhD students and one postdoctoral research fellow.
